SCHEMBL14760340

SCHEMBL14760340

O=C(O)N1CCN(c2ccc(C#Cc3ccc(C(F)(F)F)cn3)cn2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 6/20 0.54
▸ SMN1; SMN2 Q16637 5/20 0.54
▸ HTT P42858 5/20 0.54
▸ MAPT P10636 4/20 0.54
▸ HPGD P15428 1/20 0.54
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ KDM4E B2RXH2 7/20 0.50
▸ POLB P06746 1/20 0.50
▸ ALDH1A1 P00352 3/20 0.49
▸ CYP3A4 P08684 1/20 0.48
▸ ABL1 P00519 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ PANK3 Q9H999 1/20 0.48
▸ CA12 O43570 1/20 0.47
▸ CA1 P00915 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3903304 0.86 LMNA (0.69) LMNASMN1; SMN2HTTMAPTHPGD
SCHEMBL5916445 0.86 SMN1; SMN2 (0.59) LMNASMN1; SMN2HTTMAPTHPGD
SCHEMBL5916487 0.82 GAA (0.54) SMN1; SMN2MAPTHPGDMEN1KMT2A
SCHEMBL3074677 0.81 KDM4E (0.71) LMNASMN1; SMN2HTTMAPTHPGD
SCHEMBL5232948 0.77 MGLL (0.60) LMNASMN1; SMN2HTTMAPTHPGD
SCHEMBL4326148 0.76 LMNA (0.64) LMNASMN1; SMN2HTTMAPTMEN1
SCHEMBL18711414 0.75 SMN1; SMN2 (0.70) LMNASMN1; SMN2HTTMAPTHPGD
SCHEMBL29988025 0.74 SMN1; SMN2 (0.62) LMNASMN1; SMN2HTTMAPTHPGD
SCHEMBL27077767 0.74 SMN1; SMN2 (0.62) LMNASMN1; SMN2HTTMAPTHPGD
SCHEMBL4424697 0.74 LMNA (0.68) LMNASMN1; SMN2HTTMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558578-B1 NOVEL ALKYNE COMPOUNDS HAVING AN MCH ANTAGONISTIC EFFECT AND MEDICAMENTS CONTAINING THESE COMPOUNDS BOEHRINGER INGELHEIM PHARMA (DE) 2013-03-13 — — EP claimed
EP-1558578-B1 NOVEL ALKYNE COMPOUNDS HAVING AN MCH ANTAGONISTIC EFFECT AND MEDICAMENTS CONTAINING THESE COMPOUNDS BOEHRINGER INGELHEIM PHARMA (DE) 2013-03-13 — — EP disclosed
Send feedback